Alterity Therapeutics Limited (NASDAQ:ATHE) went down by -10.71% from its latest closing price compared to the recent 1-year high of $1.39. The company’s stock price has collected -13.89% of loss in the last five trading sessions.
Is It Worth Investing in Alterity Therapeutics Limited (NASDAQ :ATHE) Right Now?
Plus, the 36-month beta value for ATHE is at 1.22. Opinions of the stock are interesting as 2 analysts out of 2 who provided ratings for Alterity Therapeutics Limited declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $3.00, which is $2.5 above the current price. ATHE currently public float of 14.54M and currently shorts hold a 1.49% ratio of that float. Today, the average trading volume of ATHE was 83.21K shares.
ATHE’s Market Performance
ATHE stocks went down by -13.89% for the week, with a monthly drop of -16.78% and a quarterly performance of -18.07%, while its annual performance rate touched -60.63%. The volatility ratio for the week stands at 14.15% while the volatility levels for the past 30 days are set at 8.93% for Alterity Therapeutics Limited. The simple moving average for the period of the last 20 days is -13.81% for ATHE stocks with a simple moving average of -31.80% for the last 200 days.
ATHE Trading at -17.17% from the 50-Day Moving Average
After a stumble in the market that brought ATHE to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -64.03% of loss for the given period.
Volatility was left at 8.93%, however, over the last 30 days, the volatility rate increased by 14.15%, as shares sank -15.33% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -18.09% lower at present.
During the last 5 trading sessions, ATHE fell by -13.90%, which changed the moving average for the period of 200-days by -46.24% in comparison to the 20-day moving average, which settled at $0.5756. In addition, Alterity Therapeutics Limited saw -30.56% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for ATHE
The total capital return value is set at -103.48, while invested capital returns managed to touch -81.30. Equity return is now at value -36.30, with -32.70 for asset returns.
Based on Alterity Therapeutics Limited (ATHE), the company’s capital structure generated 0.22 points at debt to equity in total, while total debt to capital is 0.21. Total debt to assets is 0.20, with long-term debt to equity ratio resting at 0.12. Finally, the long-term debt to capital ratio is 0.12.
The liquidity ratio also appears to be rather interesting for investors as it stands at 10.92.